AU Patent

AU5874200A — Melanocortin metallopeptide constructs, combinatorial libraries and applications

Assigned to Palatin Technologies Inc · Expires 2001-03-13 · 25y expired

What this patent protects

Patent listed against bremelanotide-acetate.

Drugs covered by this patent

bremelanotide-acetate (BREMELANOTIDE ACETATE)

Patent Metadata

Patent number: AU5874200A
Jurisdiction: AU
Classification: —
Expires: 2001-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Palatin Technologies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.